Sharon Tetlow serves as Executive at CELL GENESYS INC, where they oversee executive responsibilities. Since joining the company, Sharon Tetlow has executed 7 insider transactions totaling $17.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 9, 2023 involved selling 49,841 shares valued at $0.
Sharon Tetlow currently holds 3,635 shares of CELL GENESYS INC (CEGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sharon Tetlow has been a net buyer of CEGE stock. They have purchased $17.5K and sold $0 worth of shares.
Sharon Tetlow's most recent insider trade was on Aug 9, 2023, when they sold 49,841 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 1, 2020 | CBIO | $0 | Award | 1,932 | $N/A | Discretionary |
| Jul 11, 2014 | OCRX | $17.5K | Purchase | 3,000 | $5.83 | Discretionary |
| Oct 14, 2009 | CEGE | $0 | Disposition | 18,449 | $N/A | Discretionary |
| Jul 31, 2008 | CEGE | $28.1K | Payment | 9,051 | $3.11 | Discretionary |
| Jul 30, 2007 | CEGE | $0 | Award | 25,000 | $N/A | Discretionary |